[VRDN] YoY Quarter Result on 31-Mar-2016 [#Q1]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
16-May-2016
Financial Year
2016
Quarter
31-Mar-2016 [#Q1]
Profit Trend
QoQ- 7.45%
YoY- -4.71%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
Revenue 372 4,784 462 818 645 1,091 1,139 -17.00%
PBT -11,629 -4,661 -6,980 -2,758 -2,634 -706 -537 66.91%
Tax 339 167 30 0 0 0 0 -
NP -11,629 -4,661 -6,980 -2,758 -2,634 -706 -537 66.91%
Tax Rate - - - - - - - -
Total Cost 12,001 9,445 7,442 3,576 3,279 1,797 1,677 38.79%
Ratio Analysis
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
NP Margin -3,126.08 -97.43 -1,510.82 -337.16 -408.37 -64.70 -47.14 101.12%
Per Share
31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 CAGR
EPS -5.65 -2.64 -9.06 -3.85 -6.82 -2.80 -2.86 12.01%
EPS Diluted -5.65 -2.64 -9.06 -3.85 -6.82 -2.80 -2.86 12.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.